GOGO compared with KROS: revenue, margins and what each company keeps, and the suppliers and customers both name

GOGOGogo Inc.

Mkt capRevenueRevenue

KROSKeros Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

GOGOGogo Inc.

KROSKeros Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

GOGO: latest quarter is a loss; flow not drawable. KROS: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only GOGO 5

GILTGilat Satellite Networkssupplier

—Hughesunlistedsupplier

—Intelsatunlistedsupplier

—Eutelsat OneWebunlistedsupplier

1 more · GOGO chain ›

Shared 0

No shared counterparties.

Only KROS 4

TAKTakeda Pharmaceuticalcustomer

—The General Hospitalunlistedsupplier

—Hansoh (Shanghai) Healthtechunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Takeda Pharmaceuticals U.S.A

unlistedcustomer

Price

rebased to 0%

GOGO, solidKROS, dashed

GOGOGogo Inc.

2.37· pre 2.36

Mkt cap$319.8MRevenue$223MQ2 FY26Revenue$910MFY25

KROSKeros Therapeutics, Inc.

11.04· pre 11.04· delayed

Pre-marketSep 2 '83

Mkt cap$218.9MRevenue$367,000Q1 FY26Revenue$244MFY25

Compare

Pre-marketSep 2 '83

GOGOGogo Inc.

KROSKeros Therapeutics, Inc.

2.37pre 2.36

Price

11.04pre 11.04delayed

$319.8M

Mkt cap

$218.9M

Q2 FY26$223M

Revenue

$367,000Q1 FY26

FY25$910M

Revenue

$244MFY25

GOGO2.37vsKROS11.04Pre-marketSep 2 '83